Skip to content
StingSting Logotyp


Chundsell Medicals

The company Chundsell Medicals was founded as a spin off from Cancer Center Karolinska in order to transfer the research results of Dr. Chunde Li and his group into clinical reality.

Incubate 2010

About 90 percent of prostate cancers are non-aggressive whereas the rest are aggressive tumours, which have to be treated with radical methods. Present diagnostics can’t separate these forms which bring about severe decisions. This dilemma is the basis for the novel test PCPT (Prostate Cancer Prediction Test).

Do you also want to join us?

Become one of the chosen few and be challenged to grow faster with support from some of Sweden’s leading entrepreneurs and former venture capitalists.